相关实验视频
Updated: Jan 16, 2026
08:08
Cardiopulmonary Bypass in a Mouse Model: A Novel Approach
Published on: September 22, 2017
11.6K
[现代心肺机器中心肺绕道和控制特征的管理方法]
1Department of Clinical Engineering, The University of Tokyo, Tokyo, Japan.
Kyobu geka. The Japanese journal of thoracic surgery
|September 25, 2025
概括
心肺绕道 (CPB) 管理方面的进展正在出现,包括凝血策略和氧气输送指数 (DO2i). 未来的研究将评估它们对患者治疗结果的影响,并探索用于CPB自动化监测设备的开发.
科学领域:
- 心血管外科心血管外科
- 麻醉学 麻醉学
- 输液技术的技术是输液的技术.
背景情况:
- 在过去的十年中,心肺旁路 (CPB) 管理方面取得了重大进展.
- 关键的发展包括完善的凝血管理策略和氧气输送指数 (DO2i) 和二氧化碳 (CO2) 衍生变量的整合.
- 这些创新旨在优化CPB程序期间的患者护理.
研究的目的:
- 检查近期CPB管理方面的进展对患者治疗结果的影响.
- 调查新的监控设备的潜在开发,以改善CPB管理结果为驱动.
- 通过 perfusion-assist 功能来探索自动化 CPB 操作的可行性.
主要方法:
- 关于心肺绕道治疗策略的最新文献的综述.
- 分析凝血管理中的新兴趋势.
- 在CPB中应用氧气输送指数 (DO2i) 和CO2衍生变量的评估.
- 讨论在CPB监控和自动化方面的潜在技术进步.
主要成果:
- 虽然看似微妙,但CPB管理概念的进步是显而易见的.
- 使用DO2i和CO2衍生变量为CPB期间的生理状态提供了新的见解.
- 通过采用这些先进的管理策略,预计会有更好的结果.
结论:
- 持续的研究至关重要,以将CPB管理方面的进展与患者治疗结果的可证明改善联系起来.
- 预计CPB管理的演变将刺激复杂的监控设备的开发.
- 未来的方向指向CPB操作的自动化,提高安全性和效率.
更多相关视频
相关概念视频
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
287
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
287
01:22Cardiopulmonary Resuscitation II: ACLS Airway Management
535
Airway management is a key skill in emergency and critical care settings, as maintaining a clear airway is essential for adequate oxygenation and ventilation.Head Tilt-Chin Lift TechniqueThe head tilt-chin lift maneuver is an essential technique primarily used in patients without suspected cervical spine injuries. To perform this maneuver, one hand is placed on the patient’s forehead, and gentle pressure is applied backward to tilt the head. The fingertips of the other hand are positioned...
535
01:29Cardiomyopathy V: Interprofessional Care
338
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
338
01:30Heart Failure V: Medical Management
223
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
223
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
665
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
665
01:22Heart Failure VI: Adjunct Therapies
261
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
261